可植入聚丙烯囊袋钩用于晶状体半脱位的前瞻性研究
该前瞻性非对照干预病例系列纳入74例晶状体半脱位患者,采用7-0聚丙烯缝线制作的囊袋钩联合囊袋张力环行囊袋内人工晶状体植入。随访13.2±8.9个月,人工晶状体位置稳定,最佳矫正视力从0.75±0.73 logMAR提高至0.24±0.28 logMAR(P<.05),内皮细胞密度平均丢失14.70±14.60%。结论认为该技术可行、稳定且安全。
要点
- 囊袋钩联合囊袋张力环可实现半脱位眼囊袋内IOL植入,随访期间IOL位置稳定。
- 最佳矫正视力从0.75±0.73 logMAR提高至0.24±0.28 logMAR(P<.05)。
- 内皮细胞密度平均丢失14.70±14.60%,术后并发症包括眼压升高(12.2%)等。
核心结论
- 巩膜内固定可植入囊袋钩可使晶状体半脱位眼完成囊袋内IOL植入,是一种可行、稳定且安全的方法。
研究设计与样本
- 前瞻性、非对照、干预性病例系列,纳入74例(74眼)晶状体半脱位患者,行囊袋张力环联合7-0聚丙烯缝线制作的囊袋钩辅助囊袋内IOL植入,平均随访13.2±8.9个月(范围6-36个月)。
主要发现
- 末次随访时IOL平均偏心0.31±0.24 mm、平均倾斜1.83±1.35°,随访期间IOL位置保持稳定。
- 末次随访时前房深度为3.91±0.33 mm、IOL与虹膜距离为0.65±0.26 mm,均保持稳定。
- 最佳矫正视力从术前0.75±0.73 logMAR(Snellen 20/112)提高至末次随访0.24±0.28 logMAR(Snellen 20/35)(P<.05)。
- 等效球镜从术前-2.37±4.68 D变为末次随访-1.09±1.33 D(P<.05)。
- 内皮细胞密度从术前2577.64±486.10 cells/mm2降至末次随访2171.31±707.23 cells/mm2,平均丢失14.70±14.60%(P<.05)。
关键数值与推荐
- 术中并发症为穿通巩膜壁时短暂轻度出血(n=4,5.4%)。
- 术后并发症包括眼压升高(n=9,12.2%)、低眼压(n=2,2.7%)、2级前房细胞(n=2,2.7%)、视网膜脱离(n=1,1.4%)、黄斑囊样水肿(n=1,1.4%)和后囊膜混浊(n=1,1.4%)。
临床怎么用
- 对于晶状体半脱位患者,可考虑采用巩膜内固定聚丙烯囊袋钩联合囊袋张力环辅助囊袋内IOL植入。
- 术后需监测IOL位置、眼压、内皮细胞密度及视网膜等并发症。
局限性
- 本研究为非对照病例系列,未设对照组。
- 随访时间范围为6-36个月,样本量74眼,部分并发症发生率较低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report the clinical outcomes of intrascleral fixation of implantable capsular hooks for managing subluxated lenses. DESIGN: Prospective, noncomparative, interventional case series. METHODS: Patients with subluxated lenses who underwent in-the-bag intraocular lens (IOL) implantation assisted by capsular tension ring and implantable capsular hook(s) made of 7-0 polypropylene sutures were included. The main postoperative outcome measure was IOL position, including IOL decentration, tilt, postoperative anterior chamber depth, and the distance between IOL and iris. Secondary postoperative outcomes included best-corrected visual acuity, spherical equivalent, corneal endothelial cell density, intraocular pressure, and complications. RESULTS: Seventy-four eyes of 74 patients were enrolled, with a mean follow-up of 13.2 ± 8.9 months (range: 6-36 months). The IOL position remained stable throughout the follow-up period, with a mean IOL decentration of 0.31 ± 0.24 mm and a mean tilt of 1.83 ± 1.35° at the final follow-up visit. Both postoperative anterior chamber depth and the distance between IOL and iris remained stable, with values of 3.91 ± 0.33 mm and 0.65 ± 0.26 mm at the final follow-up visit, respectively. The mean best-corrected visual acuity improved from 0.75 ± 0.73 logarithm of the minimum angle of resolution (Snellen 20/112) preoperatively to 0.24 ± 0.28 logarithm of the minimum angle of resolution (Snellen 20/35) at the final follow-up visit (P < .05). The mean spherical equivalent was -2.37 ± 4.68 D preoperatively and -1.09 ± 1.33 D at the final follow-up visit (P < .05). The mean endothelial cell density decreased from 2577.64 ± 486.10 cells/mm2 preoperatively to 2171.31 ± 707.23 cells/mm2 at the final follow-up visit with a mean loss of 14.70 ± 14.60% (P < .05). The intraoperative complication was transient mild bleeding during penetration of the scleral wall (n = 4, 5.4%). Postoperative complications included intraocular pressure elevation (n = 9, 12.2%), hypotony (n = 2, 2.7%), grade 2 anterior chamber cells (n = 2, 2.7%), retinal detachment (n = 1, 1.4%), cystoid macular edema (n = 1, 1.4%), and posterior capsule opacification (n = 1, 1.4%). CONCLUSIONS: Intrascleral fixation of implantable capsular hooks enables in-the-bag IOL implantation in eyes with subluxated lenses and represents a feasible, stable, and safe approach.
引用
- Wang Y, Cui L, Lou W, et al. Implantable Polypropylene Capsular Hook(s) for Managing Subluxated Lenses: A Prospective Study. Am J Ophthalmol. 2026. PMID: 42067050. doi:10.1016/j.ajo.2026.04.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。